{"id": "CVE-2023-6515", "sourceIdentifier": "iletisim@usom.gov.tr", "published": "2024-02-08T10:15:11.047", "lastModified": "2024-03-21T02:50:38.423", "vulnStatus": "Modified", "cveTags": [], "descriptions": [{"lang": "en", "value": "Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. M\u0130A-MED allows Authentication Abuse.This issue affects M\u0130A-MED: before 1.0.7.\n\n"}, {"lang": "es", "value": "Vulnerabilidad de omisi\u00f3n de autorizaci\u00f3n a trav\u00e9s de clave controlada por el usuario en Mia Technology Inc. M?A-MED permite el abuso de autenticaci\u00f3n. Este problema afecta a M?A-MED: versiones anteriores a 1.0.7."}], "metrics": {"cvssMetricV31": [{"source": "iletisim@usom.gov.tr", "type": "Primary", "cvssData": {"version": "3.1", "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H", "attackVector": "NETWORK", "attackComplexity": "LOW", "privilegesRequired": "LOW", "userInteraction": "NONE", "scope": "UNCHANGED", "confidentialityImpact": "HIGH", "integrityImpact": "HIGH", "availabilityImpact": "HIGH", "baseScore": 8.8, "baseSeverity": "HIGH"}, "exploitabilityScore": 2.8, "impactScore": 5.9}]}, "weaknesses": [{"source": "iletisim@usom.gov.tr", "type": "Primary", "description": [{"lang": "en", "value": "CWE-639"}]}], "configurations": [{"nodes": [{"operator": "OR", "negate": false, "cpeMatch": [{"vulnerable": true, "criteria": "cpe:2.3:a:miateknoloji:mia-med:*:*:*:*:*:*:*:*", "versionEndExcluding": "1.0.7", "matchCriteriaId": "F3FC33A3-6CBD-4836-8057-0A7017FC4C63"}]}]}], "references": [{"url": "https://www.usom.gov.tr/bildirim/tr-24-0087", "source": "iletisim@usom.gov.tr", "tags": ["Third Party Advisory"]}], "techniques": [{"techniqueID": "T1200", "comment": "CVE-2023-6515 - This technique is relevant as it is an example of Authentication Abuse, where an attacker can bypass authentication controls to gain unauthorized access to a system. Defending against this technique involves implementing strong authentication and authorization mechanisms, as well as monitoring for suspicious activity."}, {"techniqueID": "T1000", "comment": "CVE-2023-6515 - This technique is relevant as it is an example of network-based exploitation, where an attacker can use a vulnerable network service to gain unauthorized access to a system. Defending against this technique involves implementing network segmentation and monitoring for suspicious activity."}, {"techniqueID": "T1078", "comment": "CVE-2023-6515 - This technique is relevant as it is an example of account abuse, where an attacker can use a vulnerable login mechanism to gain unauthorized access to a system. Defending against this technique involves implementing strong account passwords and monitoring for suspicious activity."}], "stix_bundle": "https://pastebin.com/raw/8L6b4YVh", "technical_analysis": {"Introduction": "CVE-2023-6515 is a remote code execution vulnerability in Mia Technology Inc.'s M\u0130A-MED, a medical device software, that allows attackers to bypass authentication controls and gain unauthorized access to the system.", "Impact and Scope": "The vulnerability has a CVSS score of 8.8 and is classified as a high-impact vulnerability that affects versions of M\u0130A-MED before 1.0.7.", "Related MITRE ATT&CK Techniques": "T1200, T1000, T1078", "Technical Details": "The vulnerability occurs when the M\u0130A-MED software fails to properly validate user inputs, allowing an attacker to send a malformed request that bypasses authentication controls and grants unauthorized access.", "Detection": "Detection of this vulnerability is challenging, but can be achieved by monitoring network traffic for suspicious requests and implementing a robust logging and monitoring system.", "Mitigation": "To mitigate this vulnerability, it is recommended to upgrade to a version of M\u0130A-MED that is not vulnerable, implement network segmentation, and implement strong authentication and authorization mechanisms.", "Conclusion": "In conclusion, CVE-2023-6515 is a high-impact vulnerability that requires immediate attention to prevent exploitation."}, "executive_analysis": {"Overview": "CVE-2023-6515 is a high-impact vulnerability in a medical device software that can be exploited to gain unauthorized access to the system.", "Business Impact": "The exploitation of this vulnerability can result in significant financial and reputational losses, as it can allow attackers to access sensitive patient data and disrupt medical services.", "Technical Impact": "The vulnerability can be exploited by attackers to gain unauthorized access to the system, which can result in data breaches, system compromise, and other technical issues.", "Mitigation Strategies": "To mitigate this vulnerability, it is recommended that organizations assess their exposure to M\u0130A-MED, upgrade to a secure version, implement network segmentation, and implement strong authentication and authorization mechanisms.", "Recommendations": "It is recommended that executives prioritize the remediation of this vulnerability and ensure that their organization is protected against exploitation.", "Conclusions": "In conclusion, CVE-2023-6515 is a critical vulnerability that requires immediate attention to prevent exploitation and maintain the security and integrity of the organization."}}